DR.MAX secures contract for Blood substitutes and perfusion solutions framework agreement for the supply of drugs from the groups blood plasma substitutes and solutions for infusions drugs used in cardiology

Romania, April 27 -- Romania based DR.MAX has secured contract from Operator SEAP for Blood substitutes and perfusion solutions framework agreement for the supply of drugs from the groups blood plasma substitutes and solutions for infusions drugs used in cardiology. The value of the contract is worth 16440 RON.

Published by HT Digital Content Services with permission from Pivotal Sources....